739 - A Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Mild to Moderate Ulcerative Colitis: Results of a Phase 2A Clinical Trial Showing Promising Results
Authors:
- Einat AlmonEAEinat Almon
- Eran GoldinEGEran Goldin
- Wisam SbeitWisam Sbeit
- Eran IsraeliEIEran Israeli
- Doron SchwartzDSDoron Schwartz
- Ofer Ben-BassatOBOfer Ben-Bassat
- Matti WatermanMWMatti Waterman
- Nikola MilinicNMNikola Milinic
- Boris VladimirovBVBoris Vladimirov
- Mali SzlaiferMSMali Szlaifer
- Hadar ReuveniHRHadar Reuveni
- Bat-Chen Amit CohenBCBat-Chen Amit Cohen
- 1 May 2018
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)